Loss of PILRA promotes microglial immunometabolism to reduce amyloid pathology in cell and mouse models of Alzheimer’s disease | Science Translational Medicine
PILRA is a therapeutic target for Alzheimer’s disease that regulates neuroinflammation and metabolism in microglia.
